Impact we've achieved with our research:
This research has provided a groundbreaking insight into the relationship between the protein dyskerin and neuroblastoma, a deadly childhood cancer.
This project has worked to improve treatments and reduce the major challenge of some breast cancer patients’ resistance to endocrine therapy and relapse.
Professor Robert Baxter and his team have tested a promising new therapy, which can effectively block the growth of triple negative breast cancer by inhibiting two proteins that act as stimu
Professor Xu Dong Zhang and his team investigated the role a particular protein plays in melanoma cell survival.
Prof David Gottlieb's research arose out of a desire to overcome poor outcomes in clinical practice. He wants to develop better treatments that can have direct and clear benefits for patient